<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010037938">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Vanhollebeke, B.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Nielsen, M. J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Watanabe, Y.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Truc, Philippe</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Vanhamme, L.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Nakajima, K.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Moestrup, S. K.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Pays, E.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Distinct roles of haptoglobin-related protein and apolipoprotein L-1 in trypanolysis by human serum</title>
        <secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title>
      </titles>
      <pages>4118-4123</pages>
      <keywords>
        <keyword>innate immunity</keyword>
        <keyword>sleeping sickness</keyword>
        <keyword>trypanolytic factor</keyword>
        <keyword>haptoglobin receptor</keyword>
        <keyword>Trypanosoma brucei</keyword>
      </keywords>
      <dates>
        <year>2007</year>
      </dates>
      <call-num>fdi:010037938</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title>
      </periodical>
      <isbn>0027-8424</isbn>
      <accession-num>CC:0002449724-0080</accession-num>
      <number>10</number>
      <electronic-resource-num>10.1073/pnas.0609902104</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010037938</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2024-12/010037938.pdf</url>
        </pdf-urls>
      </urls>
      <volume>104</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Apolipoprotein L-I (apoL-I) is a human high-density lipoprotein (HDL) component able to kill Trypanosoma brucei brucei by forming anion-selective pores in the lysosomal membrane of the parasite. Another HDL component, haptoglobin-related protein (Hpr), has been suggested as an additional toxin required for full trypanolytic activity of normal human serum. We recently reported the case of a human lacking apoL-I (apoL-I-/-HS) as the result of frameshift mutations in both apoL-I alleles. Here, we show that this serum, devoid of any trypanolytic activity, exhibits normal concentrations of HDL-bound Hpr. Conversely, the serum of individuals with normal HDL-bound apoL-I but who lack Hpr and haptoglobin [Hp(r)-/-HS] as the result of gene deletion (anhaptoglobinemia) exhibited phenotypically normal but delayed trypanolytic activity. The trypanolytic properties of Hp(r)-/-HS were mimicked by free recombinant apoL-I, whereas recombinant Hpr did not affect trypanosomes. The lysis delay observed with either Hp(r)-/-HS or recombinant apoL-I could entirely be attributed to a defect in the uptake of the lytic components. Thus, apoL-I is responsible for the trypanolytic activity of normal human serum, whereas Hpr allows fast uptake of the carrier HDL particles, presumably through their binding to an Hp/Hpr surface receptor of the parasite.</abstract>
      <custom6>052</custom6>
    </record>
  </records>
</xml>
